Person: AY, NADİYE PINAR
Loading...
Email Address
Birth Date
Research Projects
Organizational Units
Job Title
Last Name
AY
First Name
NADİYE PINAR
Name
13 results
Search Results
Now showing 1 - 10 of 13
Publication Metadata only Excess mortailty during Covid-19 pandemic in Istanbul(2021-09-01) AY, NADİYE PINAR; Musellim B., Kul S., Ay P., Uyanusta C., Dagli E., Itil O., Bayram H.Publication Open Access Research publications from the ATS MECOR program in Turkiye(2023-01-01) ARIKAN, HÜSEYİN; AY, NADİYE PINAR; Karakurt Z., Yilmaz O., ARIKAN H., AY N. P., Demir C., Gurkan C. G., Akgun M., Buist S.Background: The American Thoracic Society (ATS) Methods in Epidemiologic, Clinical, and Operations Research (MECOR) Program aims to build research capacit in low and middle-income countries. MECOR has three levels, during which students learn to develop a research protocol and write a manuscript. MECOR Turkiye has been offered every year since 2008. Objective: The aim of this paper is to report the number and impact of published articles generated from research questions developed by students in levels 1, 2, and 3 of the ATS MECOR Program in Turkiye between 2008 and 2018. Methods: We collected the research questions developed in all levels of the ATS MECOR Program in Turkiye between 2008 and 2018. We searched Google Scholar, PubMed, Web of Science, and ResearchGate in April 2022 to see how many of these research questions were published as articles and, if published, in which journals. Results: Of the 176 research questions collected, 49 had been developed in level 1, 82 had been developed in level 2, and 45 had been developed in level 3. Of those 176 research questions, 55 (31.3%) generated articles that were accepted for publication. The frequency of published articles based on MECOR-developed research questions increased linearly as the course level in which they were developed increased (18.4% in level 1, 30% in level 2, 46.7% in level 3; P = 0.012; linear-by-linear association, P = 0.003). The median time from the development of the research question to publication was three years overall and did not differ significantly among the course levels (P = 0.36). Of the research questions developed, 43 were published in Science Citation Index or Science Citation Index Expanded–indexed journals. Conclusion: Acceptance of an article for publication is one way to measure the impact of the ATS MECOR Program. Our data describe significant research output among our participants, which increases with their length of participation in the program.Publication Metadata only Curcumventing the Menthol Ban: Internet sales of menthol balls(2022-09-01) AY, NADİYE PINAR; Dagli E., Sonmez U. P., Guner M., Elbek O., Ay P., Yildiz F., Gezer T., Ceyhan M.Aim: Menthol makes smokers inhale more deeply and increase exposure time with its cooling effect on the airways. Use of menthol in tobacco products was banned in Turkey since 5th January 2022. This study aims to investigate the internet sales of a new product called "menthol ball" which is made to inject menthol into regular cigarettes. Method: “Menthol Ball" key word was Google searched. Out of 45,500 data retrieved 1696 relevant ones were further investigated. Web sites of the products, e-commerce websites,social media accounts were detected. Their promotional activities, methods of trading were noted. Results: 37 brands of menthol balls were detected. All brands promote their products through videos describing the injection of the tiny menthol balls into the classical cigarettes. Only 12 have their individual website, the other 25 use main e-commerce outlets to reach to the customers. Two menthol ball brands market their products in one-kilogram bags at e-commerce sites. One brand market a "menthol ball liquid" for roll-your-own tobacco. Three major e-commerce sites sell 1485 different flavored menthol balls under the category of air refresher. One other e-commerce site sold 88 various menthol balls under the category of tobacco bags. Conclusion: Banning menthol in tobacco products help prevent youth starting to smoke or lower smoking rates among vulnerable communities . However freely sold menthol that can be injected into the cigarettes may reincarnate menthol cigarettes. Any product that will circumvent menthol ban must be restricted.Publication Metadata only Three years' follow up: relationship of maternal depression and anxiety with ever-wheezing(2021-09-01) AY, NADİYE PINAR; Yilmaz O., Yasar A., Ocalan M., AY N. P., ALKIN T., Hasdemir S., Yuksel H.Our previous data had not shown an association between wheezing during the first year life and maternal depression and anxiety. The aim of this study was to investigate the role of prenatal maternal depression and anxiety as risk factors for ever-wheezing in the first three years of life. Mother-infant pairs enrolled between 2016-2018 formed the population of this study (n=697). All subjects were phoned and questioned about wheezing and physician diagnosis of asthma. Age and maternal education, smoking habits, Edinburgh postnatal depression scale(EPDS) and State Trait Anxiety Inventory 1,2(STAI) scores during the last trimester were recorded from previous cohort data. Among 285 children enrolled, 84(%29.5) had ever-wheezing in the first 3 years of life. Mean age of wheezers and non-wheezers were 39.6±8.2 and 39.1±7.3 months respectively (p=0.13). Mean maternal age was not significantly different between the groups (p=0.16). 47,6% of ever-wheezers and %54.7 of non-wheezers were females (p=0.29). Family history of asthma was not signficantly different between the two groups (p=0.84). Current maternal smoking was reported by 40.5% of ever-wheezers and 41.3% of non-wheezers (p=1.0). Maternal smoking before and during pregnancy were 16.7% and 4.8% in ever-wheezers while 10.9% and 7.5% in never-wheezers respectively (p=0.33). Prenatal maternal depression was present in 17(20.2%) of ever-wheezers compared to 45(22.4%) of non-wheezers (p=0.75). Maternal depression and anxiety at three months postpartum were not significantly different (10.7 in wheezers,15.4% in non-wheezers, p=0.35). In conclusion, prenatal depression and anxiety was not related to ever-wheezing during the first three years of life.Publication Metadata only How do we manage asthma? Assessment of knowledge, attitude, and practice patterns among pulmonologists and allergists(2022-01-01) AY, NADİYE PINAR; GÜNAYDIN F. E., AY N. P., KARAKAYA G., EDİGER D.Objective: The objective of this study was to evaluate and compare knowledge, attitude, and practice patterns between pulmonologists and allergists for adult asthma in Turkey. Methods: Questionnaire-based data were gathered from 236 pulmonologists and 62 allergists, who had been members of the Turkish Thoracic Society and Turkish National Society of Allergy and Clinical Immunology in January-March 2021. Univariate and multivariate statistics were used to determine the factors associated with primary reliever preferences. Results: Of the 298 physicians, 39% encountered at least five asthma patients daily. Spirometer was used frequently by both the allergists (82.3%) and pulmonologists (77.5%) for asthma diagnosis. Budesonide was the most preferred inhaler corticosteroid. Formoterol/budesonide was the most preferred ICS/LABA combination, followed by beclomethasone/formoterol and fluticasone/salmeterol for asthma treatment. For mild asthmatics, formoterol/ICS was the most preferred (72.6%) reliever among allergists, whereas salbutamol was the most preferred (66.1%) among pulmonologists (p < 0.001). Age and workplace were associated with salbutamol preference of doctors for mild asthmatics. Age, specialty, and patient examination time were significantly associated with salbutamol preference for severe asthmatics. Conclusions: The use of diagnostic tools, such as a spirometer, for asthma diagnosis was compatible with the guidelines. While recent updates of the guidelines indicate that salbutamol should not be used solely in mild asthmatics due to its harmful effects in long-term use, it still was the most preferred drug by pulmonologists. Postgraduate education programs are needed to improve compliance with the guidelines.Publication Metadata only New Product at Point of Sales : Menthol ball(2022-09-01) AY, NADİYE PINAR; Dagli E., Pece U., Guner M., Yildiz F., Elbek O., Ay P., Gezer T., Ceyhan M.Aim: Point of sales (POS) advertising bans had been legislated in many countries without adequate enforcement. The aim of this study is to identify new products and devices at POS that could facilitate tobacco or nicotine use. Method: Shadow reporting at POS methodology developed by Framework Convention Alliance was used to investigate the products sold in four commercially dense districts of Istanbul. POS in one kilometer radius were visited by walking tour at each district. The products their display and compliance with legislation were noted. Results: Out of 198 POS visited 31 sell a product called "menthol ball". These were tiny colorful balls of menthol mixed with other various aromas that are sold together with an instrument that stab the end of a standard cigarette and insert the ball into the cigarette. The POS closest to schools were more likely to stock metholl balls. Majority of the POS placed the menthol balls close to candies, mints, chewing gums at eye level of children, just below the cigarette shelf. Conclusion: Tobacco industry uses menthol to sustain addiction among adolescents. Menthol use in cigarettes was banned on 5th January 2020 in Turkey. Using menthol balls to "make your own cigarette" is a novel technique developed by the industry to appeal the youth. Public health community needs to be vigilant and take actions.Publication Metadata only Point of Sale Display of Plain Cigarette Packages : Finger prints of the industry(2021-09-01) AY, NADİYE PINAR; Dagli E., Sonmez U., Guner M., Gezer T., Ay P., Elbek O., Yildiz F., Ceyhan M.Objective: Tobacco industry has been using the point of sales (POS) as a promotion outlet for their products. Previously, in Istanbul, the complience with the advertising ban has been found to be low. This study aims to investigate the effect of plaing packaging implementation on the compliance of the POS in 2020. Method: This observational study was carried out at the six trade-dense districts of Istanbul by using the "Framework Convention Alliance Shadow Reporting" Methodology in 2020. All the POS in 1 km diameter were visited. A form is filled about the display format and photos were taken. Results: Of the 177 POS visited ; at 100 % the display was at the eye-level of children, at 97 % the shelves contained tobacco advertising, at 92% the tobacco products were visible from outside the shop, at 85 % the stacking of the packs were against the legislation, at 80 % tax stamps were covering the pictorial warnings, at 73 % the display shelves were donations of the tobacco companies, at 52 % the pictorial warning were invisible due to perpendicular placement, at 31 % the shop sign indicated a tobacco brand. The same violation strategy was recorded in 93% of the sale points throughout various districts. A stacking design with various pack sizes was noted in all shops. Measurements and Main Results: A consistent pattern of stacking that made the pictorial warning invisible was noted in the majority of the POS in various districts of the city, indicating orchestrated industry interference. The findings of this study implies that plain packaging renders pictorial warnings prominent. The displays at POS must be made visible to the eye of the consumers by preventing industry interference.Publication Metadata only Point of sales: Playground of the tobacco industry(2022-09-01) AY, NADİYE PINAR; Dagli E., Sonmez U. P., Guner M., Elbek O., Yildiz F., Ay P., Gezer T., Ceyhan M.Publication Metadata only Survey on the compliance with plain packaging regulation(2021-09-01) AY, NADİYE PINAR; Dagli E., Gezer T., Ay P., Guner M., Elbek O., Yildiz F., Ceyhan M.Publication Metadata only Effect of standardized hands-on-training in caregivers of children with tracheostomy(2021-09-01) AY, NADİYE PINAR; GÖKDEMİR, YASEMİN; Yegit C. Y., Kilinc A. A., Gulieva A., Atag E., Yazan H., Oksay S. C., Kostereli E., UZUNER S., Onay Z. R., Hepkaya E., et al.